Cargando…

Invasive pneumococcal disease and long-term outcomes in children: A 20-year population cohort study

BACKGROUND: Although vaccination against Streptococcus pneumoniae infections (such as invasive pneumococcal disease (IPD)) are available, challenges remain in prevention efforts. Moreover, downstream sequelae in children is relatively unknown. Thus, we aimed to evaluate short and long-term health ou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Versluys, Kristen A., Eurich, Dean T., Marrie, Thomas J., Forgie, Sarah, Tyrrell, Gregory J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903925/ https://www.ncbi.nlm.nih.gov/pubmed/36777393 http://dx.doi.org/10.1016/j.lana.2022.100341

Ejemplares similares

Invasive Pneumococcal Disease and Long-Term Mortality Rates in Adults, Alberta, Canada
por: Versluys, Kristen A., et al.
Publicado: (2022)

Rates of, and risk factors for, septic arthritis in patients with invasive pneumococcal disease: prospective cohort study
por: Marrie, Thomas J., et al.
Publicado: (2017)

Invasive Pneumococcal Disease: Still Lots to Learn and a Need for Standardized Data Collection Instruments
por: Marrie, T. J., et al.
Publicado: (2017)

Prognostic factors associated with mortality and major in-hospital complications in patients with bacteremic pneumococcal pneumonia: Population-based study
por: Beatty, Jessica A., et al.
Publicado: (2016)

Concurrent Infection with Hepatitis C Virus and Streptococcus pneumoniae
por: Marrie, Thomas J., et al.
Publicado: (2017)

Population-based cohort study of outpatients with pneumonia: rationale, design and baseline characteristics
por: Eurich, Dean T, et al.
Publicado: (2012)

Epidemic of Invasive Pneumococcal Disease, Western Canada, 2005–2009
por: Tyrrell, Gregory J., et al.
Publicado: (2012)

Population-Based Surveillance for Invasive Pneumococcal Disease in Homeless Adults in Toronto
por: Plevneshi, Agron, et al.
Publicado: (2009)

Risk of heart failure after community acquired pneumonia: prospective controlled study with 10 years of follow-up
por: Eurich, Dean T, et al.
Publicado: (2017)

Pneumococcal Serotypes and Mortality following Invasive Pneumococcal Disease: A Population-Based Cohort Study
por: Harboe, Zitta B., et al.
Publicado: (2009)

Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands
por: Knol, Mirjam J., et al.
Publicado: (2015)

Pneumococcal Meningitis in Adults: A Prospective Nationwide Cohort Study Over a 20-year Period
por: Koelman, Diederik L H, et al.
Publicado: (2021)

Whole-Genome Analysis of Streptococcus pneumoniae Serotype 4 Causing Outbreak of Invasive Pneumococcal Disease, Alberta, Canada
por: Kellner, James D., et al.
Publicado: (2021)

Impact of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease and pneumonia in The Gambia: 10 years of population-based surveillance
por: Mackenzie, Grant A, et al.
Publicado: (2021)

2596. Title: The Dynamics Of Invasive Pneumococcal Disease (IPD) due to Streptococcus pneumoniae and Impact Of Pneumococcal Conjugate Vaccines (PCVs) In Canada From 2000-2019
por: Ramos, Bernice N, et al.
Publicado: (2023)

Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease among 948,263 individuals ≥ 65 years of age: a Danish cohort study
por: Nielsen, Katrine Finderup, et al.
Publicado: (2022)

Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease
por: Melegaro, Alessia, et al.
Publicado: (2010)

Burden of invasive pneumococcal disease in children in Casablanca, Morocco four years after the introduction of pneumococcal vaccination
por: Chikhaoui, Amar, et al.
Publicado: (2022)

Gastrointestinal symptoms in invasive pneumococcal disease: a cohort study
por: Floeystad, Hans Kristian, et al.
Publicado: (2020)

1738. Cost-Effectiveness Analysis of Infant Pneumococcal Vaccination with the 20-Valent Pneumococcal Conjugate in the US
por: Rozenbaum, Mark, et al.
Publicado: (2023)

Acute organ injury and long-term sequelae of severe pneumococcal infections
por: Kruckow, Katherine L., et al.
Publicado: (2023)

Comparison of the Impact of Pneumococcal Conjugate Vaccine 10 or Pneumococcal Conjugate Vaccine 13 on Invasive Pneumococcal Disease in Equivalent Populations
por: Naucler, Pontus, et al.
Publicado: (2017)

Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
por: Vila-Corcoles, Angel, et al.
Publicado: (2010)

Impact of pneumococcal conjugate vaccine on invasive pneumococcal disease in children under 5 years of age in the Czech Republic
por: Kozakova, Jana, et al.
Publicado: (2021)

Changes in Invasive Pneumococcal Disease in the Paediatric Population in the Second COVID-19 Pandemic Year
por: Izquierdo, Conchita, et al.
Publicado: (2023)

Invasive Pneumococcal Disease and 7-Valent Pneumococcal Conjugate Vaccine, the Netherlands
por: van Deursen, Anna M.M., et al.
Publicado: (2012)

Feasibility and Long-Term Efficacy of PEComa Treatment—20 Years of Experience
por: Sobiborowicz, Aleksandra, et al.
Publicado: (2021)

Pneumococcal vaccine uptake and vaccine effectiveness in older adults with invasive pneumococcal disease in Germany: A retrospective cohort study
por: Perniciaro, Stephanie, et al.
Publicado: (2021)

Serotype-specific differences in short- and longer-term mortality following invasive pneumococcal disease
por: HUGHES, G. J., et al.
Publicado: (2016)

1436. Risk Factors for Invasive Pneumococcal Disease in Adults ≥65 Years Old Following Pneumococcal Conjugate Vaccine Recommendation
por: Almendares, Olivia M, et al.
Publicado: (2018)

Missed Pneumococcal Vaccination Opportunities in Adults With Invasive Pneumococcal Disease in a Community Health System
por: Schulz, Paul S, et al.
Publicado: (2022)

Mathematical Modelling Long-Term Effects of Replacing Prevnar7 with Prevnar13 on Invasive Pneumococcal Diseases in England and Wales
por: Choi, Yoon Hong, et al.
Publicado: (2012)

Medication transitions and polypharmacy in older adults following acute care
por: Gamble, John-Michael, et al.
Publicado: (2014)

Immunogenicity of a 20-valent pneumococcal conjugate vaccine in adults 18 to 64 years old with medical conditions and other factors that increase risk of pneumococcal disease
por: Sabharwal, Charu, et al.
Publicado: (2022)

Invasive Pneumococcal Disease in a Population with Underlying Comorbidities
por: Jarovsky, Daniel, et al.
Publicado: (2017)

Impact of Ten-Valent Pneumococcal Conjugate Vaccination on Invasive Pneumococcal Disease in Finnish Children – A Population-Based Study
por: Jokinen, Jukka, et al.
Publicado: (2015)

Invasive Pneumococcal Disease after Routine Pneumococcal Conjugate Vaccination in Children, England and Wales
por: Ladhani, Shamez N., et al.
Publicado: (2013)

Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age
por: Hurley, Donald, et al.
Publicado: (2020)

Correction to “Pneumococcal vaccine uptake and vaccine effectiveness in older adults with invasive pneumococcal disease in Germany: A retrospective cohort study”
por: Perniciaro, Stephanie, et al.
Publicado: (2022)

1160. Comparative Effectiveness of Pneumococcal Vaccination Strategies to Prevent Invasive Pneumococcal Disease: A Cohort Study at the Veterans Health Administration
por: Goto, Michihiko, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rmmft4m4l2kpo8gtdro5b8o8eb